Our search for autoantibodies revealed anti-AP3B2 autoantibodies in serum.<h4>Conclusions</h4>Our report expands the spectrum of symptoms to mild cognitive impairment in addition to a gait disturbance associated with anti-AP3B2 autoantibodies. Here, AP3B2 is linked to Cognitive impairment.